21.72美元0.08(0.37%)
2023/09/25更新
績效 / 1月1.26%
3月0.32%
1年15%
晨星評等-
- 1.現金0.00%
- 2.股票36.51%
- 3.債券0.00%
- 4.其他63.49%
- 1.美國63.49%
- 2.歐洲不包含歐元區22.40%
- 3.日本5.58%
- 4.英國4.61%
- 5.歐元區2.31%
- 1.健康護理96.85%
- 2.工業2.04%
- 3.基本物料0.62%
- 4.防守性消費0.49%
- 1.Novo Nordisk A/S Class B8.94%
- 2.UnitedHealth Group Inc8.31%
- 3.Eli Lilly and Co6.92%
- 4.Roche Holding AG6.40%
- 5.Amgen Inc5.19%
- 6.Vertex Pharmaceuticals Inc5.18%
- 7.Regeneron Pharmaceuticals Inc5.05%
- 8.Elevance Health Inc4.82%
- 9.Gilead Sciences Inc4.71%
- 10.GSK PLC4.50%
- 1.現金0.00%
- 2.股票36.51%
- 3.債券0.00%
- 4.其他63.49%
- 1.健康護理96.85%
- 2.工業2.04%
- 3.基本物料0.62%
- 4.防守性消費0.49%
- 1.美國63.49%
- 2.歐洲不包含歐元區22.40%
- 3.日本5.58%
- 4.英國4.61%
- 5.歐元區2.31%
- 1.Novo Nordisk A/S Class B8.94%
- 2.UnitedHealth Group Inc8.31%
- 3.Eli Lilly and Co6.92%
- 4.Roche Holding AG6.40%
- 5.Amgen Inc5.19%
- 6.Vertex Pharmaceuticals Inc5.18%
- 7.Regeneron Pharmaceuticals Inc5.05%
- 8.Elevance Health Inc4.82%
- 9.Gilead Sciences Inc4.71%
- 10.GSK PLC4.50%